Trials / Sponsors / Boston Therapeutics
Boston Therapeutics
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes Type2 Diabetes Mellitus | Phase 2 | 2018-09-19 |
| Completed | Determination of the GI and II Values of Soft Drink and Soft Drink With Sugardown™ Postprandial Hyperglycemia | N/A | 2014-11-01 |
| Completed | Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With Metfor Type 2 Diabetes Mellitus | N/A | 2014-05-01 |
| Withdrawn | The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients Type II Diabetes | Phase 2 | 2012-09-01 |
| Completed | Determination of the PPG and Insulin Responses of Rice Alone and Rice Consumed With Sugardown™ Postprandial Hyperglycemia | N/A | 2011-03-01 |
| Completed | Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes Type 2 Diabetes Treated With Insulin | Phase 2 | 2011-03-01 |